大動脈内カウンターパルセーション装置の世界市場-2023年～2030年

概要

大動脈内対流拍動装置は、心臓が血液をより効果的に送り出すのを助けるように設計された医療機器です。主に重症の心臓疾患、特に心不全や心原性ショックの管理、あるいは特定の心臓手術の際に使用されます。この装置は、大動脈の血流のタイミングを調節することで機能します。大動脈は、心臓から体内に酸素を含んだ血液を運ぶ主要な動脈です。

大動脈内拍動装置にはさまざまな種類があるが、大動脈内バルーンポンプと大動脈内カニューレが最も普及しています。これらの機器は、血流と冠動脈灌流を改善するため、心臓の重篤な状態において極めて重要です。

市場力学：促進要因

世界の心臓発作の有病率の増加が市場成長の原動力になると予想されます

世界心臓連盟によると、心血管疾患（CVD）による死亡者数は1990年の1,210万人から2021年には2,050万人へと世界的に急増しました。CVDは心臓と血管の疾患群で、冠動脈性心疾患、脳血管疾患、リウマチ性心疾患などが含まれます。CVDによる死亡の5人に4人以上は心臓発作と脳卒中によるもので、その3分の1は70歳未満で早死にします。

IACDは心拍出量を増加させ冠動脈血流を改善させるので、急性心疾患の管理に不可欠です。心臓発作や重症心不全のような状況では、IACDは心臓に一時的な負担を軽減し、重要な臓器の灌流をサポートします。そのため、心血管疾患（CVD）関連の死亡率が上昇し、症例が複雑化していることから、IACDに対する需要が高まっています。これらの機器は、重篤な状態にある患者の命綱となり、死亡率を低下させ、治療の質を高める可能性があります。

その結果、ヘルスケアプロバイダーはますますその救命の可能性を認識し、治療戦略に取り入れるようになっており、これがIACD市場の成長を促進しています。さらに、高齢化人口の増加とリスクの高い心臓手術の増加が、予測期間中に市場を牽引すると予想される要因となっています。

市場力学：抑制要因：

大動脈内カウンターパルセーション装置市場は、製品リコール、高コスト、熟練オペレーターの不足、潜在的な合併症によって阻害される可能性があります。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 世界の心臓発作の有病率の増加
  • 抑制要因
    • 製品リコールの増加
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• パイプライン分析
• 特許分析
• DMIオピニオン

第6章 COVID-19分析

第7章 製品タイプ別

• 大動脈内バルーンポンプ（IABP）
• 大動脈内カニューレ

第8章 適応症別

• 心筋梗塞
• 心原性ショック
• 心不全
• その他

第9章 エンドユーザー別

• 病院
• 外来手術センター
• 心臓専門センター
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ

第11章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第12章 企業プロファイル

• Teleflex Incorporated
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• Getinge
• Zeon Medical Inc.
• Abiomed, Inc.

第13章 付録

Overview

Intra-aortic counterpulsation device is a medical device designed to help the heart pump blood more effectively. It is mainly used to manage severe heart conditions, especially heart failure, cardiogenic shock, or during certain cardiac procedures. The device works by adjusting the timing of blood flow in the aorta the primary artery that carries oxygenated blood from the heart to the body.

There are various types of intra-aortic counterpulsation devices, but the intra-aortic balloon pump and intra-aortic cannula are the most popular. These devices are crucial in critical cardiac conditions as they improve blood flow and coronary artery perfusion.

Market Dynamics: Drivers

The increasing prevalence of heart attacks worldwide is expected to drive market growth

According to the World Heart Federation, deaths from cardiovascular disease (CVD) surged globally from 12.1 million in 1990 to 20.5 million in 2021. CVDs are a group of disorders of the heart and blood vessels and include coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other conditions. More than four out of five CVD deaths are due to heart attacks and strokes, and one-third of these deaths occur prematurely in people under 70 years of age.

IACDs are essential in managing acute cardiac conditions as they help increase cardiac output and improve coronary blood flow. In scenarios like heart attacks or severe heart failure, IACDs can provide temporary relief to the heart, reducing strain, and supporting vital organ perfusion. Therefore, due to the rising prevalence of cardiovascular disease (CVD)-)-related fatalities and the increasing complexity of cases, there is a growing demand for IACDs. These devices can be a lifeline for patients in critical conditions, potentially reducing mortality rates and enhancing the quality of care.

As a result, healthcare providers are increasingly recognizing their lifesaving potential and incorporating them into their treatment strategies, which is driving growth in the IACD market. Furthermore, the growing aging population and an increasing number of high-risk cardiac procedures are the factors expected to drive the market over the forecast period.

Market Dynamics: Restraint:

The market for intra-aortic counterpulsation devices may be hindered by product recalls, high costs, shortage of skilled operators, and potential complications.

Segment Analysis

The global intra-aortic counterpulsation device market is segmented based on product type, surgical approach, technology, end-user and region.

The Intra-Aortic Balloon Pump (IABP) from the Product Type Segment Accounted for Approximately 47.8% of the Coagulation Analyzers Market Share

The Intra-Aortic Balloon Pump (IABP) is a medical device used to assist the heart in pumping blood more effectively. It is primarily employed in the management of patients with severe heart conditions, particularly those experiencing heart failure, cardiogenic shock, or undergoing certain cardiac procedures. The device operates by altering the timing of blood flow within the aorta, the main artery that carries oxygenated blood from the heart to the rest of the body.

Moreover, owing to the increasing prevalence of cardiovascular diseases, and the growing aging population are the factors expected to drive the market over the forecast period.

For instance, according to the Journal of Heart Association Article 2022, the global burden of cardiovascular disease is increasing, especially among older adults. The most common diseases in this demographic are congestive heart failure, coronary artery diseases, hypertension, atrial fibrillation, peripheral arterial disease, valvular heart disease, and stroke. Older adults with cardiovascular disease have complex and severe conditions due to comorbidities and geriatric syndromes, which puts them at higher risk of functional decline and complications.

Therefore, IABPs are essential in providing temporary support for older adults who suffer from advanced cardiovascular conditions, serving as a crucial bridge to more definitive treatments such as coronary interventions or cardiac surgeries. These devices help stabilize patients, optimize their condition, and improve their readiness for surgical procedures.

Moreover, IABPs can significantly improve the overall prognosis of older adults with cardiovascular disease. By reducing the workload on the heart and enhancing cardiac output, these devices contribute to better outcomes and increase the chances of survival. Hence, owing to the above factors, the market segment is expected to hold the largest market share over the forecast period.

Geographical Analysis

North America Accounted for Approximately 39.8% of the Market Share in 2022

North America region is expected to hold the largest market share over the forecast period owing to the increasing prevalence of myocardial infarction, and growing cardiac surgeries. For instance, according to the Society of Thoracic Surgeons (STS) National Adult Cardiac Surgery Database reported that in 2021, there were approximately 5,048 total cardiac surgeries performed. Therefore, there is an increase in demand for Intra-Aortic Counterpulsation Devices (IACDs) may increase due to the positive impact of the total number of cardiac surgeries.

In contrast, the market is being negatively affected by product recalls. One such example is the Class I level recall in the U.S. by Teleflex, which involved the Arrow AutoCAT 2 and AC3 Optimus intra-aortic balloon pumps. The recall was due to a potential breakdown of motor connector wires.

Competitive Landscape

The major global players in the intra-aortic counterpulsation device market include: Teleflex Incorporated, Getinge, Zeon Medical Inc., and Abiomed, Inc. among others.

COVID-19 Impact Analysis:

The COVID-19 pandemic has had a significant effect on cardiac surgery worldwide. Many hospitals have had to reduce or suspend non-emergency surgeries, including cardiac surgeries, to conserve resources for COVID-19 patients. This has reduced the number of surgeries performed and the backlog of patients waiting for surgery. As per the article published in the Archives of Cardiovascular Diseases in 2021, cardiac surgery systematically requires postoperative intensive care. As these specialized units were reserved for patients with COVID-19 necessitating respiratory support, elective open-heart surgeries were substantially delayed in almost all french centers.

Furthermore, some cardiac patients may be at a higher risk of severe illness from COVID-19 due to underlying heart conditions, which may make them more hesitant to seek treatment. The pandemic also decreased the number of patients admitted to hospitals for heart attacks, which is believed to be due to people being afraid to seek medical attention out of fear of getting COVID-19. This decreased hospital revenue, resulting in some downsizing of services, including cardiac services.

Overall, the COVID-19 pandemic has had a significant impact on cardiac surgery worldwide, leading to a decrease in the number of surgeries being performed and a backlog of patients waiting for surgery, as well as affecting the availability of medical staff and equipment and leading to a decrease in revenue for hospitals.

Why Purchase the Report?

• To visualize the global intra-aortic counterpulsation device market segmentation based on product type, indication, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous data points of intra-aortic counterpulsation device market-level with all segments
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study
• Product mapping available as excel consisting of key products of all the major players

The global intra-aortic counterpulsation device market report would provide approximately 43 tables, 52 figures, and 170 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Indication
• 3.3. Snippet by End User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. The increasing prevalence of heart attacks worldwide
  • 4.1.2. Restraints
    • 4.1.2.1. Increasing product recalls
  • 4.1.3. Opportunity
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's Five Force Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis
• 5.5. Pipeline Analysis
• 5.6. Patent Analysis
• 5.7. DMI Opinion

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID
  • 6.1.2. Scenario During COVID
  • 6.1.3. Scenario Post COVID
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During the Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product Type

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 7.1.2. Market Attractiveness Index, By Product Type
• 7.2. Intra-Aortic Balloon Pump (IABP)*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Intra-Aortic Cannula

8. By Indication

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 8.1.2. Market Attractiveness Index, By Indication
• 8.2. Myocardial Infarction*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Cardiogenic Shock
• 8.4. Heart Failure
• 8.5. Others

9. By End User

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 9.1.2. Market Attractiveness Index, By End User
• 9.2. Hospitals*
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Ambulatory Surgical Centers
• 9.4. Specialty Heart Centers
• 9.5. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. UK
    • 10.3.6.3. France
    • 10.3.6.4. Spain
    • 10.3.6.5. Italy
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Indication
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Teleflex Incorporated*
  • 12.1.1. Company Overview
  • 12.1.2. Product Portfolio and Description
  • 12.1.3. Financial Overview
  • 12.1.4. Key Developments
• 12.2. Getinge
• 12.3. Zeon Medical Inc.
• 12.4. Abiomed, Inc.

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us